Tag Archives: China grants country’s first COVID-19 vaccine patent

BEIJING: China’s vaccine specialist CanSino Biologics has won a patent approval from Beijing for its COVID-19 vaccine candidate Ad5-nCOV, state media reported, citing documents from the country’s intellectual property regulator. It is the first COVID-19 vaccine patent granted by China, state-owned newspaper People’s Daily reported on Sunday. The paper cited documents published by China’s National Intellectual Property Administration saying that …

Read More »